Heartsciences Inc HSCS

$2.95 -0.04 (-1.34%)

Valuation

Market cap
14,858,000
Revenue TTM
$4,319
Net income TTM
$-9,140,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
60,600
Avg volume
170,308
Day's range
$2.88 – $3.16
Shares out
4,969,000
Stochastic %K
10%
Beta
1.80
Analysts
Moderate Buy
Price target
$10.00

Price

Company profile

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfuncti...

Show more

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic ECG management platform. The company was formerly known as Heart Test Laboratories, Inc. and changed its name to HeartSciences Inc. in October 2024. HeartSciences Inc. was incorporated in 2007 and is headquartered in Southlake, Texas.

Industry
Medical Devices
Sector
Healthcare
Phone
682 237 7781
Website
https://heartsciences.com
Address
550 Reserve Street, Suite 360, Southlake, United States

Latest news